Tumour necrosis factor‐α signalling has been shown to participate in cerebral neuroinflammation after stroke (Hallenbeck, 2002); thus, the use of anti‐TNF‐α or recombinant TNF‐α to examine its role in stroke‐induced gut dysfunction in vivo may also impact brain infarct development. This evidence concerns the gene TNF and stroke disorder.